2024 Q2 Form 10-Q Financial Statement

#000121390024048321 Filed on May 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $929.0K $1.099M $3.000K
YoY Change 819.8% 343.15% -99.62%
Cost Of Revenue $620.0K $779.0K $5.000K
YoY Change 1450.0% 433.56% -99.07%
Gross Profit $309.0K $320.0K -$2.000K
YoY Change 406.56% 213.73% -100.78%
Gross Profit Margin 33.26% 29.12% -66.67%
Selling, General & Admin $584.0K $1.234M $154.0K
YoY Change 150.64% 570.65% -53.89%
% of Gross Profit 189.0% 385.63%
Research & Development $0.00 -$43.00K
YoY Change -100.0% -165.15%
% of Gross Profit 0.0%
Depreciation & Amortization $15.00K $69.00K
YoY Change
% of Gross Profit 4.85% 21.56%
Operating Expenses $584.0K $1.234M $111.0K
YoY Change 145.38% 455.86% -72.25%
Operating Profit -$275.0K -$914.0K -$113.0K
YoY Change 55.37% 661.67% -20.42%
Interest Expense $15.00K $4.000K $924.0K
YoY Change -93.36% -96.46% -263.83%
% of Operating Profit
Other Income/Expense, Net $15.00K -$10.00K -$79.00K
YoY Change -93.36% -91.53%
Pretax Income -$260.0K -$993.0K $732.0K
YoY Change -630.61% 317.23% -203.68%
Income Tax
% Of Pretax Income
Net Earnings -$284.0K -$1.000M $732.0K
YoY Change -679.59% 320.17% -203.68%
Net Earnings / Revenue -30.57% -90.99% 24400.0%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 $0.05
COMMON SHARES
Basic Shares Outstanding 213.7M shares 213.7M shares 11.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $173.0K $157.0K $12.00K
YoY Change 118.99% 175.44% -92.86%
Cash & Equivalents $173.0K $157.0K $12.00K
Short-Term Investments
Other Short-Term Assets $1.959M $160.0K $0.00
YoY Change 17709.09% 7900.0% -100.0%
Inventory $847.0K $892.0K $0.00
Prepaid Expenses
Receivables $870.0K $1.134M
Other Receivables $0.00 $799.0K
Total Short-Term Assets $3.979M $3.275M $12.00K
YoY Change 2148.02% 1430.37% -96.52%
LONG-TERM ASSETS
Property, Plant & Equipment $69.00K $78.00K $0.00
YoY Change
Goodwill $8.978M $327.0K $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.400M
YoY Change
Other Assets $1.000K
YoY Change
Total Long-Term Assets $9.757M $9.454M $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.979M $3.275M $12.00K
Total Long-Term Assets $9.757M $9.454M $0.00
Total Assets $13.74M $12.73M $12.00K
YoY Change 7660.45% 5848.13% -96.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.812M $1.966M $327.0K
YoY Change 1132.65% 4472.09% 595.74%
Accrued Expenses $1.548M $146.0K
YoY Change 338.53% -48.77%
Deferred Revenue
YoY Change
Short-Term Debt $1.616M $1.304M $1.398M
YoY Change 28.46% 2.68% 13.84%
Long-Term Debt Due $21.00K
YoY Change
Total Short-Term Liabilities $5.258M $5.407M $2.064M
YoY Change 129.21% 122.88% -11.03%
LONG-TERM LIABILITIES
Long-Term Debt $37.00K $710.0K $0.00
YoY Change
Other Long-Term Liabilities $145.0K $153.0K $0.00
YoY Change 37217.07%
Total Long-Term Liabilities $182.0K $863.0K $0.00
YoY Change 210387.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.258M $5.407M $2.064M
Total Long-Term Liabilities $182.0K $863.0K $0.00
Total Liabilities $5.440M $6.270M $2.064M
YoY Change 137.14% 158.45% -11.03%
SHAREHOLDERS EQUITY
Retained Earnings -$13.78M -$13.74M -$12.74M
YoY Change 7.73% 7.06% 1.14%
Common Stock $21.00K $20.00K $1.000K
YoY Change 2000.0% 1900.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.154M $6.283M -$2.052M
YoY Change
Total Liabilities & Shareholders Equity $13.74M $12.73M $12.00K
YoY Change 7660.45% 5848.13% -96.52%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$284.0K -$1.000M $732.0K
YoY Change -679.59% 320.17% -203.68%
Depreciation, Depletion And Amortization $15.00K $69.00K
YoY Change
Cash From Operating Activities -$77.00K $165.0K -$110.0K
YoY Change -450.0% -273.68% 547.06%
INVESTING ACTIVITIES
Capital Expenditures $8.661M $795.0K
YoY Change
Acquisitions $8.400M
YoY Change
Other Investing Activities -$8.401M
YoY Change
Cash From Investing Activities -$260.0K -$9.523M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 353.0K $9.503M 87.00K
YoY Change -59493.75% 45.0%
NET CHANGE
Cash From Operating Activities -77.00K $165.0K -110.0K
Cash From Investing Activities -260.0K -$9.523M
Cash From Financing Activities 353.0K $9.503M 87.00K
Net Change In Cash 16.00K $145.0K -23.00K
YoY Change -27.27% -230.63% -153.49%
FREE CASH FLOW
Cash From Operating Activities -$77.00K $165.0K -$110.0K
Capital Expenditures $8.661M $795.0K
Free Cash Flow -$8.738M -$630.0K
YoY Change -39818.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-56239
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SAMSARA LUGGAGE, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0299456
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
6 Broadway
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 934
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10004
CY2024Q1 dei City Area Code
CityAreaCode
917
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
522-3202
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
213730601 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
892000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1134000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
799000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
133000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
160000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3275000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
12000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000 usd
CY2024Q1 saml Capital Work In Progress Amount
CapitalWorkInProgressAmount
648000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
8400000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
327000 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
9454000 usd
CY2024Q1 us-gaap Assets
Assets
12729000 usd
CY2023Q4 us-gaap Assets
Assets
12000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1966000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
327000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1548000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
146000 usd
CY2024Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1304000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1398000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5407000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2064000 usd
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
710000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
153000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
863000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6270000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2064000 usd
CY2024Q1 saml Convertible And Redeemable Preferred Share Par Value
ConvertibleAndRedeemablePreferredShareParValue
0.0001
CY2023Q4 saml Convertible And Redeemable Preferred Share Par Value
ConvertibleAndRedeemablePreferredShareParValue
0.0001
CY2024Q1 saml Convertible And Redeemable Preferred Shares Authorized
ConvertibleAndRedeemablePreferredSharesAuthorized
1000000 shares
CY2023Q4 saml Convertible And Redeemable Preferred Shares Authorized
ConvertibleAndRedeemablePreferredSharesAuthorized
1000000 shares
CY2024Q1 saml Convertible And Redeemable Preferred Shares Outstanding
ConvertibleAndRedeemablePreferredSharesOutstanding
0 shares
CY2023Q4 saml Convertible And Redeemable Preferred Shares Outstanding
ConvertibleAndRedeemablePreferredSharesOutstanding
80698 shares
CY2024Q1 saml Convertibleand Redeemable Preferred Stock Value
ConvertibleandRedeemablePreferredStockValue
0 usd
CY2023Q4 saml Convertibleand Redeemable Preferred Stock Value
ConvertibleandRedeemablePreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
352500 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
35000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
175000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
0 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13922414 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13922414 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4406312 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4406312 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
20000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19972000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10625000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13744000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12744000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6459000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2118000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12729000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12000 usd
CY2024Q1 us-gaap Revenues
Revenues
1099000 usd
CY2023Q1 us-gaap Revenues
Revenues
248000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
779000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
146000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
320000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
102000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1232000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1234000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
222000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-914000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-120000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
113000 usd
CY2024Q1 saml Incomeexpenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan
IncomeexpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoan
-6000 usd
CY2023Q1 saml Incomeexpenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan
IncomeexpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoan
-5000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-118000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
69000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-993000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-238000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100093920 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4996213 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2118000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
775000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
83000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
80000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
168000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8463000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-993000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6459000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2136000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
41000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-238000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2333000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-993000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-238000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
69000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
58000 usd
CY2023Q1 saml Expenses In Respect Of Warrants Issued And Convertible Component In Convertible Loan Net Interest Expenses
ExpensesInRespectOfWarrantsIssuedAndConvertibleComponentInConvertibleLoanNetInterestExpenses
6000 usd
CY2024Q1 saml Operating Loss Before Working Capital Changes
OperatingLossBeforeWorkingCapitalChanges
-924000 usd
CY2023Q1 saml Operating Loss Before Working Capital Changes
OperatingLossBeforeWorkingCapitalChanges
-174000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1134000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
892000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
293000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-19000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1639000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1402000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
69000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2000 usd
CY2024Q1 us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
-397000 usd
CY2023Q1 us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
4000 usd
CY2024Q1 us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
799000 usd
CY2024Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-769000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
165000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
795000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8400000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
327000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9523000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-16000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9503000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9503000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
145000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-111000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
41000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
350000 shares
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A critical accounting estimate is an estimate that: (i) is made in accordance with generally accepted accounting principles, (ii) involves a significant level of estimation uncertainty and (iii) has had or is reasonably likely to have a material impact on the Company’s financial condition or results of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts and related disclosures. On an ongoing basis, management evaluates and updates its estimates. Management employs judgment in making its estimates but they are based on historical experience and currently available information and various other assumptions that the Company believes to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates. Management believes that its judgment is applied consistently and produces financial information that fairly depicts the results of operations for all periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract-based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-993000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-238000 usd
CY2024Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-1000000 usd
CY2023Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-238000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100093920 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4996213 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
100093920 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
4996213 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
452620462 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5022765 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26552 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26552 shares
CY2024Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
352500000 shares
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
160000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2024Q1 saml Total Related Party Receivables
TotalRelatedPartyReceivables
799 usd
CY2023Q4 saml Total Related Party Receivables
TotalRelatedPartyReceivables
0 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
65968000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1000000000 usd
CY2024Q1 saml Capital Work In Progress
CapitalWorkInProgress
100000000 usd
CY2024Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.01 pure
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1134000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
8400000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
350000 shares
CY2024Q1 us-gaap Equity Fair Value Disclosure
EquityFairValueDisclosure
8599569000 usd
CY2024Q1 us-gaap Goodwill Transfers
GoodwillTransfers
199569000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
11000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5407000 usd
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1966000000 usd
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1966000 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
78754.69 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1666666 shares
CY2024Q1 us-gaap Payments For Proceeds From Removal Costs
PaymentsForProceedsFromRemovalCosts
7500 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
26552 shares
CY2024Q1 saml Warrants To Purchase Shares
WarrantsToPurchaseShares
26552 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1714286 shares
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
272000 usd
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
1000 usd
CY2024Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
21000 usd
CY2024Q1 us-gaap Communication
Communication
3000 usd
CY2024Q1 us-gaap Cost Maintenance
CostMaintenance
3000 usd
CY2024Q1 us-gaap Utilities Operating Expense Maintenance And Operations
UtilitiesOperatingExpenseMaintenanceAndOperations
6000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
66000 usd
CY2024Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
19000 usd
CY2024Q1 saml Rental Expenses
RentalExpenses
52000 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
790000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1232000 usd
CY2024Q1 us-gaap Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
600685 usd
CY2024Q1 saml Convertible Shares
ConvertibleShares
150753425 shares
CY2024Q2 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
11557 usd
CY2024Q1 us-gaap Revenues
Revenues
1099000 usd
CY2023Q1 us-gaap Revenues
Revenues
248000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
779000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
146000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
320000 usd
CY2024Q1 saml Percentage Of Gross Profit Margin
PercentageOfGrossProfitMargin
0.25 pure
CY2023Q1 us-gaap Gross Profit
GrossProfit
102000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1234000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
222000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-993000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-238000 usd
CY2024Q1 saml Working Capital Deficit
WorkingCapitalDeficit
157000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
12000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2064000 usd
CY2023Q4 saml Working Capital Deficit
WorkingCapitalDeficit
2052000 usd
CY2024Q1 saml Net Cash Provided By Used Of Operating Activities
NetCashProvidedByUsedOfOperatingActivities
230000 usd
CY2023Q1 saml Net Cash Provided By Used Of Operating Activities
NetCashProvidedByUsedOfOperatingActivities
-95000 usd
CY2024Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
9523000 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0 usd
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q1 us-gaap Depreciation
Depreciation
usd
CY2023Q1 us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
usd
CY2023Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
usd
CY2024Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2024Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001530163

Files In Submission

Name View Source Status
0001213900-24-048321-index-headers.html Edgar Link pending
0001213900-24-048321-index.html Edgar Link pending
0001213900-24-048321.txt Edgar Link pending
0001213900-24-048321-xbrl.zip Edgar Link pending
ea0207068-10q_samsara.htm Edgar Link pending
ea020706801ex31-1_samsara.htm Edgar Link pending
ea020706801ex32-1_samsara.htm Edgar Link pending
ea020706801ex4-1_samsara.htm Edgar Link pending
ea020706801ex4-2_samsara.htm Edgar Link pending
ea020706801ex4-3_samsara.htm Edgar Link pending
ex4-1_001.jpg Edgar Link pending
ex4-1_002.jpg Edgar Link pending
ex4-2_001.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
ea0207068-10q_samsara_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
saml-20240331.xsd Edgar Link pending
Show.js Edgar Link pending
saml-20240331_def.xml Edgar Link unprocessable
saml-20240331_lab.xml Edgar Link unprocessable
saml-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
saml-20240331_cal.xml Edgar Link unprocessable